Qualities Tied to Potential Scientific Bias

Overestimation of effect sizes in meta-analyses is linked with early-career status, small collaborations, or misconduct records, according to a study.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

© BRYAN SATALINOLooking for patterns of potential bias in scientific studies, a Stanford University–based research team found a number of risk factors. Among more than 3,000 meta-analyses, small studies that were highly cited were more likely to contain bias, as were studies authored by scientists with a history of misconduct or by small but global research teams. On the other hand, the study, published in PNAS yesterday (March 20), found no association between bias and the authors’ country of origin giving incentives to individuals for performance, refuting the idea of a “publish or perish” environment.

“To the best of my knowledge, all the evidence that we have about pressures to publish comes from surveys, i.e. what scientists say. Now, there is no question that these pressures exist, we all feel them, and it is reasonable to suspect that they might have negative effects on the literature,” coauthor Daniele Fanelli told Retraction Watch. “However, as scientists we should verify empirically whether these concerns are justified or not. And, to the best of my current understanding, as explained above, evidence suggests that they are partially misguided.”

Fanelli and colleagues collected data from more than 3,000 meta-analyses, and looked for correlations among various characteristics, such as authors’ retraction history, citations, career level, and gender, as well as studies’ effect sizes. Scientists who had ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform